Idaho · 64642

Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, First Extremity in Idaho

Idaho Medicare Avg
$74.89
20% below national avg
National Medicare Avg
$93.73
All states combined
Billed Charge (ID)
$255.10
What providers submit
Est. Commercial (ID)
$205.68
National avg: $277.64
Est. Cash / Self-Pay (ID)
$143.61
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

213
Services in ID
29
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in Idaho

Provider Medicare Services
Friedman, Robert MD $100.19 31

Idaho Pricing in Context

In Idaho, CPT code 64642 (Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, First Extremity) carries an average Medicare payment of $74.89 — 20% below the national benchmark of $93.73. 29 providers across the state submitted claims for this procedure in 2023, performing 213 total services. Individual payments in ID ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Idaho is $255.10, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Idaho sits below the national Medicare average, commercial rates in the state may also run lower than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Nervous System Surgery procedures, the estimated commercial insurance price in Idaho lands near $205.68, with self-pay cash prices typically around $143.61. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, First Extremity cost in Idaho?

The average Medicare payment for Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, First Extremity in Idaho is $74.89, which is 20% below the national average of $93.73. Providers in ID typically bill $255.10 for this procedure.

What does Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, First Extremity cost with insurance in Idaho?

With commercial insurance in Idaho, Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, First Extremity costs an estimated $205.68. Without insurance, the estimated cash price is $143.61. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, First Extremity in Idaho?

29 providers in Idaho billed Medicare for Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, First Extremity in 2023, performing 213 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, First Extremity cheaper in Idaho than the national average?

Yes — Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, First Extremity costs 20% below the national average in Idaho. The state average Medicare payment is $74.89 compared to $93.73 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial